Vascular Grafts Market Report 2026

Vascular Grafts Market Overview

• Vascular Grafts market size has reached to $3.86 billion in 2025 • Expected to grow to $5.35 billion in 2030 at a compound annual growth rate (CAGR) of 6.9% • Growth Driver: High Prevalence Of Cardiovascular Diseases Drives Global Vascular Grafts Market • Market Trend: Introduction Of Innovative Products For Vascular Disorders • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Vascular Grafts Market?

The vascular grafts are used to repair the diseased or blocked blood vessel during the surgical procedure called vascular grafting or vascular bypass. Vascular grafting is performed to bypass a partial or complete blockage in an artery by reconnecting the blood vessels. This process improves the blood flow by redirecting blood from one area of the body to another. The main products of the vascular grafts market are hemodialysis access graft, endovascular stent graft, peripheral vascular grafts, and coronary artery bypass graft. Endovascular stent graft refers to the method of minimally invasive method that is used to treat an aortic aneurysm and is performed to know the presence of abdominal pain, symptoms for the disease, and also for the size of the aneurysm. The various raw materials are polyester grafts, ePTFE, polyurethane grafts, and biosynthetic grafts. The various applications of vascular grafts are coronary artery disease, aneurysm, vascular occlusion, and renal failure that are used by end-users such as hospitals and ambulatory surgical centers.

What Is The Vascular Grafts Market Growth Forecast?

The vascular grafts market size is expected to see strong growth in the next few years. It will grow to $5.35 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to adoption of tissue-engineered grafts, AI-driven patient-specific graft design, growth in minimally invasive surgery, integration with intraoperative imaging, increasing geriatric population requiring vascular interventions. Major trends in the forecast period include bioengineered and tissue-engineered grafts, ai-assisted graft design, minimally invasive implant techniques, integration with imaging and monitoring systems, customized patient-specific grafts.

Global Vascular Grafts Market Segmentation

1) By Product: Hemodialysis Access Graft, Endovascular Stent Graft, Peripheral Vascular Graft, Coronary Artery By-Pass Graft 2) By Raw Material: Polyester Grafts, Polytetrafluoroethylene Grafts, Polyurethane Grafts, Biosynthetic Grafts 3) By Application: Coronary Artery Disease, Aneurysm, Vascular Occlusion, Renal Failure 4) By End-User: Hospitals, Ambulatory Surgical Centers Subsegments: 1) By Hemodialysis Access Graft: Synthetic Grafts, Biological Grafts 2) By Endovascular Stent Graft: Aneurysm Stent Grafts, Thoracic Stent Grafts, Abdominal Stent Grafts 3) By Peripheral Vascular Graft: Synthetic Grafts, Biological Grafts 4) By Coronary Artery Bypass Graft (Cabg): Arterial Grafts, Venous Grafts

What Is The Driver Of The Vascular Grafts Market?

The rising incidence of cardiovascular diseases is expected to propel the growth of the vascular grafts market going forward. Cardiovascular diseases refer to a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart failure, and stroke. The rise in cardiovascular diseases can be attributed to unhealthy eating habits, where excessive consumption of processed foods and fats leads to higher cholesterol levels, increasing heart risks. Vascular grafts support cardiovascular disease treatment by restoring or bypassing damaged blood vessels, improving blood flow, and reducing the risk of complications. They enhance patient outcomes by enabling effective surgical interventions and supporting long-term cardiovascular health. For instance, in October 2024, according to the Centers for Disease Control, a US-based government agency, in 2023, approximately 919,032 people died from cardiovascular disease, accounting for 1 in every 3 deaths. Therefore, the rising incidence of cardiovascular diseases is driving the growth of the vascular grafts industry.

Key Players In The Global Vascular Grafts Market

Major companies operating in the vascular grafts market are B. Braun Melsungen AG, Abbott Laboratories, W. L. Gore & Associates Inc., Terumo Medical Corporation, Medtronic Plc, Endologix, Cook Medical, MicroPort, CR Bard, Biovic, Novomed Incorporation Private Limited, Gore Medical, LeMaitre Vascular, JOTEC, Vascutek, RUA Life Sciences, Vascular Flow Technologies, Bolton Medical, Cryolife, Vascular Graft Solutions Ltd.

Global Vascular Grafts Market Trends and Insights

Major companies operating in the vascular grafts market are focused on introducing innovative products to gain a competitive edge in the market. Innovative products refer to the development of new and advanced technologies that can be used to treat vascular disorders. These products are designed to provide a durable and reliable conduit for blood flow and to overcome the limitations of traditional vascular grafts. For instance, in January 2023, Viz.ai, a US-based medical technology company that specializes in artificial intelligence (AI)-powered software, launched the AI-Powered Viz Vascular Suite. It uses artificial intelligence to automatically analyze an array of imaging modalities, including computerized tomography (CT), electrocardiogram (ECG), and more for suspected vascular diseases. If a suspected pathology is found, the app automatically alerts and displays high-fidelity patient scans on providers’ mobile devices. Clinicians can use Viz Vascular Suite to remotely coordinate vascular pathology care within a hospital system’s hub and spoke network and enable synchronous, HIPAA-compliant communication among specialists. The platform is enhanced by AI for immediate team activation and facilitates informed, efficient treatment decisions.

What Are Latest Mergers And Acquisitions In The Vascular Grafts Market?

In April 2025, Healthcare Holding Switzerland AG, a Switzerland-based medical-technology services provider, acquired Schaublin Medica SA for an undisclosed amount. With this acquisition, Healthcare Holding aims to strengthen its cardiovascular and vascular surgery portfolio by integrating Schaublin Medica’s expertise in vascular grafts, endoprostheses, stents, and drug-coated balloon catheters. Schaublin Medica SA is a Switzerland-based cardiovascular medical device company specializing in vascular grafts.

Regional Outlook

North America was the largest region in the vascular grafts market in 2025. Western Europe was the second largest region in the vascular grafts market report. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Vascular Grafts Market?

The vascular grafts market consists of sales of polytetrafluoroethylene (Teflon), polyethylene terephthalate (Dacron), or a different person's vein (allograft). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.